@M_Chalasani

Tweets are my own. Follows/Retweet ≠ endorsement.

 Silver Spring, MD
Joined July 2009
  • Tweets3K
  • Following589
  • Followers374
188Media
FDA releases white paper on Selective Safety Data Collection. SSDC is the planned reduction in certain data collection for drugs with well-characterized safety profiles. White paper discusses trials that have used SSDC in oncology & cardiometabolic spaces. fda.gov/media/187763/downloa…
FDA logo on a blue background with text 'White Paper: Selective Safety Data Collection' and the C3TI logo.

ALT FDA logo on a blue background with text 'White Paper: Selective Safety Data Collection' and the C3TI logo.

1
4
5
2,289
The CDER Center for Clinical Trial Innovation (C3TI) demonstration project on Bayesian methods is expanding its scope to include pre-specified primary analysis and trial monitoring, in addition to its previous focus on supplementary analysis. Learn more: fda.gov/about-fda/cder-cente…
Digital circuit design with abstract lines and arrows on a dark blue background, featuring the logo of the FDA in the lower right corner.

ALT Digital circuit design with abstract lines and arrows on a dark blue background, featuring the logo of the FDA in the lower right corner.

1
5
5
2,594
Have you subscribed to our Center for Clinical Trial Innovation updates yet? Click on fda.gov/about-fda/center-dru…, and then click 'Subscribe to Email Updates' at the top of the page. Enter your email address to receive timely updates on innovative approaches to clinical trials.
Logo for the FDA's CDER Center for Clinical Trial Innovation (C3TI) on a blue background with molecular structures.

ALT Logo for the FDA's CDER Center for Clinical Trial Innovation (C3TI) on a blue background with molecular structures.

2
3
2,318
Meghana Chalasani retweeted
U.S. FDA
@FDA20 May 2024
Today is Clinical Trials Day! We remain committed to supporting clinical research including engaging patients and caregivers to understand their unique perspectives to promote innovative clinical trial design. #FDAVoices fda.gov/news-events/fda-voic…
3
18
2
35
8,216
Today, we announced the launch of the CDER Center for Clinical Trial Innovation (C3TI). C3TI’s mission is to promote CDER clinical trial innovation activities through enhanced communication and collaboration, both internally within CDER and externally: fda.gov/drugs/drug-safety-an…
Blue abstract background. Text includes: CDER Center for Clinical Trial Innovation (C3TI). Small FDA Logo in bottom right corner.

ALT Blue abstract background. Text includes: CDER Center for Clinical Trial Innovation (C3TI). Small FDA Logo in bottom right corner.

2
4
4
3,802
FDA is extending the nomination deadline for academicians and clinicians to serve as members of the new Genetic Metabolic Diseases Advisory Committee to March 12, 2024. Submit a nomination: accessdata.fda.gov/scripts/F…
FDA Drugs and Biologics
@FDADrugs12 Dec 2023
Today, FDA is announcing a new Genetic Metabolic Diseases Advisory Committee (GeMDAC) to help the agency explore the complex issues related to genetic metabolic disease drug development: fda.gov/news-events/press-an…
Graphic of 5 people sitting around a table in meeting. Text reads “Genetic Metabolic Diseases Advisory Committee (GeMDAC). FDA logo on bottom right corner.

ALT Graphic of 5 people sitting around a table in meeting. Text reads “Genetic Metabolic Diseases Advisory Committee (GeMDAC). FDA logo on bottom right corner.

3
1
3,863
Meghana Chalasani retweeted
FDA Drugs and Biologics
@FDADrugs1 Feb 2024
Join FDA, with @DukeMargolis, for a hybrid public workshop to discuss efforts to advance innovation of clinical trial design and conduct. 📅 March 19 & 20 both on-site and virtual Learn more & register➡️fda.gov/drugs/news-events-hu…
Blue background with dozens of silhouettes of people in a crowd. Text graphic states "Public Workshop March 19-20, 2024"

ALT Blue background with dozens of silhouettes of people in a crowd. Text graphic states "Public Workshop March 19-20, 2024"

2
4
1,984
❔ Have ideas on how to innovate clinical trials to overcome barriers? Help shape the future of clinical trial design by commenting on the FDA docket. 💬 Learn more: fda.gov/drugs/drug-safety-an… #RareDisease
Graphic of a hand pointing to a magnifying glass in a search bar with the words "Clinical Trial" in black font

ALT Graphic of a hand pointing to a magnifying glass in a search bar with the words "Clinical Trial" in black font

2
5
2,694
Please share with your networks and encourage relevant experts to apply! FDA is accepting applications until February 11, 2024.
FDA Drugs and Biologics
@FDADrugs12 Dec 2023
Today, FDA is announcing a new Genetic Metabolic Diseases Advisory Committee (GeMDAC) to help the agency explore the complex issues related to genetic metabolic disease drug development: fda.gov/news-events/press-an…
Graphic of 5 people sitting around a table in meeting. Text reads “Genetic Metabolic Diseases Advisory Committee (GeMDAC). FDA logo on bottom right corner.

ALT Graphic of 5 people sitting around a table in meeting. Text reads “Genetic Metabolic Diseases Advisory Committee (GeMDAC). FDA logo on bottom right corner.

2
86
Meghana Chalasani retweeted
U.S. FDA
@FDA12 Dec 2023
Today, we announced the agency is creating a new advisory committee related to potential treatments for genetic metabolic diseases. fda.gov/news-events/press-an…
4
6
1
19
6,357
To understand the state of innovation in clinical trial design and conduct, CDER is soliciting public comments and gathering information on the barriers and facilitators to incorporating innovative clinical trial approaches in drug development programs: fda.gov/drugs/drug-safety-an…
Image of raised hands with text that states "FDA requests public comments on clinical trial innovation"

ALT Image of raised hands with text that states "FDA requests public comments on clinical trial innovation"

1
1
1
3
3,836
👗 @MoCoRec is collecting gently used and new dresses, suits and accessories students will be able to choose from during “Project Prom Dress,” a giveaway event on Saturday, April 15, at Praisner Community Recreation Center in Burtonsville. Details ➡️ ow.ly/sWbq50MHcSv.
9
19
4,051
Happy Thursday… 🧡
48
4
110
Overwhelming feeling of appreciation and gratitude today…wish you and yours a Happy Thanksgiving!
3
We celebrated the establishment of the Naga P. Chalasani endowed chair last night. I always knew I had an accomplished mentor, but to hear he did it all while maintaining relationships with family & friends made it all more special. Congratulations! @nagachalasani @IUGastro
6
5
2
77
With the support of generous donors, the @nagachalasani Endowed Chair campaign reached $2.5 million. 🎉 Last night we were joined by friends/family to honor his lifetime of accomplishments. Thank you to @rajVuppaLanchi and Dr. Ghabril for co-chairing the campaign. #LiverTwitter
Drs. Vuppalanchi, Chalasani and Ghabril.

ALT Drs. Vuppalanchi, Chalasani and Ghabril.

Dr. Chalasani speaking.

ALT Dr. Chalasani speaking.

Dr. Chalasani, his son and his wife.

ALT Dr. Chalasani, his son and his wife.

5
2
33
Happy #NationalDogDay, Jade! 🐶❤️
2
Congrats @nagachalasani!!! 👏🏽👏🏽👏🏽Immensely proud of you for your hard work, dedication, ability to inspire all those around you, and of course, this tremendous honor! ❤️
Indiana University Gastroenterology and Hepatology@IUGastro17 Aug 2022
We're excited to announce the @nagachalasani Endowed Chair in Gastroenterology and Hepatology. 💪 Dr. Chalasani has served #iugastro for 15 years and his mentorship, leadership, strength and compassion for faculty, staff and anyone he comes into contact with is unmatched. 🧵⬇️
7
Join FDA and @NIH on August 24 at 3 PM ET for a virtual webinar to learn about the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS). Register: fda.gov/news-events/fda-meet…
A graphic image of a brain and the FDA logo.

ALT A graphic image of a brain and the FDA logo.

1
3
1
4
Meghana Chalasani retweeted
U.S. FDA
@FDA23 Jun 2022
Today we unveiled our ACT for ALS Action Plan, a 5-year strategy for improving & extending the lives of people living with rare neurodegenerative diseases. fda.gov/news-events/press-an…
A graphic image of a brain. Text: FDA releases action plan for rare neurodegenerative diseases, including ALS

ALT A graphic image of a brain. Text: FDA releases action plan for rare neurodegenerative diseases, including ALS

10
24
12
65
Load more